Jupiter Topco LLC purchased a new position in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 92,200 shares of the company’s stock, valued at approximately $4,096,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its position in Docusign by 8.2% during the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after purchasing an additional 165 shares during the last quarter. Centaurus Financial Inc. boosted its holdings in Docusign by 3.4% in the 3rd quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock valued at $402,000 after purchasing an additional 184 shares during the last quarter. Tred Avon Family Wealth LLC grew its stake in shares of Docusign by 3.6% in the 1st quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after buying an additional 215 shares during the period. Sanctuary Advisors LLC grew its stake in shares of Docusign by 2.4% in the 4th quarter. Sanctuary Advisors LLC now owns 9,685 shares of the company’s stock valued at $662,000 after buying an additional 231 shares during the period. Finally, First Citizens Bank & Trust Co. increased its holdings in shares of Docusign by 2.1% during the 1st quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock worth $557,000 after buying an additional 239 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Docusign Stock Performance
Shares of DOCU stock opened at $64.64 on Wednesday. The firm has a market cap of $12.34 billion, a P/E ratio of 41.97, a P/E/G ratio of 1.92 and a beta of 0.90. The firm’s 50 day moving average price is $54.35 and its 200-day moving average price is $49.43. Docusign Inc. has a one year low of $40.16 and a one year high of $86.65.
Analyst Upgrades and Downgrades
DOCU has been the topic of several analyst reports. UBS Group set a $60.00 price target on shares of Docusign in a research report on Friday, June 5th. Wedbush cut their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Weiss Ratings upgraded Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 25th. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Finally, Wall Street Zen cut Docusign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 2nd. Four investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $60.27.
Check Out Our Latest Analysis on DOCU
Insider Buying and Selling at Docusign
In related news, CEO Allan C. Thygesen sold 26,250 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $46.02, for a total value of $1,208,025.00. Following the sale, the chief executive officer owned 159,038 shares in the company, valued at approximately $7,318,928.76. The trade was a 14.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $546,480.00. Following the transaction, the insider directly owned 52,815 shares in the company, valued at approximately $2,405,195.10. The trade was a 18.51% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 90,965 shares of company stock valued at $4,341,688. Corporate insiders own 0.59% of the company’s stock.
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
- Five stocks we like better than Docusign
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
